I notice the profile information states CPRX has a total of 6 full time employees. This seems to be a relatively small number for a biotech in this stage of its pipeline development. Does anyone have insight/opinion as to if this is accurate? If so, is there any weight to place on a total employee number for a biotech with an $80M market cap? Comparisons? Etc?
Sentiment: Strong Buy
The awesome part is that the article not only shows on Yahoo's Headlines under INO but also under Merck's! Imagine all those that read Merck's headlines on a daily basis and have never heard of INO...until now! Great exposure!!
I don't know about you all but I get so consumed by all this hour by hour price watching and message board reading lunacy. Hard not to get excited but the emotions are taxing. Time to delete INO from my watch list for a while, believe in the investment, and enjoy life. Best of luck to all.
Sentiment: Strong Buy
let's make sure to make the distinction between trading and investing. i don't view my purchase of INO as a trade and would hate to miss out on a potential 10,000% return by taking off half of my position just because i'm up 100%. There can be just as strong of an argument in certain cases, and this may be one, that one should continue to buy more as your conviction and belief in the management, prospects and value of the company strengthens.
You really think bashers on a Yahoo message board have a penny influence on how a stock trades? I think not. Waste of time.
So ACHN, prior to its after-hours drop, has a market cap of $800M+. Like INO, it's still in development stages with no revenues. I only show a Phase II trial completed, one other in stage other than a few other initial trial studies. How is INO only valued at $160M then? Granted you might say ACHN is just further along with its trials but still nothing proven. Is it just a matter of time then for INO?
thanks for that clarification. so we already got our bump from the announcement of the offering. Hoping once they finalize the repurchase the 6.78M shares of the parent's common stock held by Chesapeake and settle all current litigation with them that we'll get some more movement. I believe this is in June?
Closing of the sale is projected for tomorrow, 5/15. Any indications on the interest purchasing of the Notes so far? Are we likely to get a pop once the closing is announced and it was well received (i.e. sold the full $200 million)? Does this come in the form of a company PR announcment? This is new to me...
Yesterday I used my $5,000 2012 Roth IRA contribution limit to purchase 129 shares of LNCO at $38.50. I'm 37 and looking at a 30 year holding period for this stock. According to my investment calculator, with the assumption of an 8% annual return and no further contributions, my $5,000 investment will grow to $54,679 when I'm 67 (in today's $). Understanding there are risks to any investment, anyone have any assumptions/opinions based on that expected rate of return over 30 years for LNCO? Conservative? Aggressive?